WASHINGTON — Federal health officials announced a pilot program Monday to speed up early-stage clinical trials, which they ...

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. The Trump administration ...

Health disparities researchers say a new White House proposal could disqualify much of their work from federal funding — ...

Sanofi said that Paulo Fontoura, the chief medical officer at Xaira, would be taking over as its head of R&D, as the company ...

They’ve blown past last year’s totals in roughly half the amount of time. Pharma companies struck 26 blockbuster M&A deals in ...

Matthew Herper covers medical innovation — both its promise and its perils. Pfizer said Monday that an experimental drug it hoped could replace a widely used chemotherapy in one of the most common ...

The psychiatric ER is “a detox center for those with no safe place to withdraw and a respite center for caregivers at their ...

An NIH grant proposal poses new threats, more cases of a livestock disease in Europe, and more health news from Morning ...

Nearly 30% of the data collected in clinical trials do not directly inform key decisions, yet patients are still asked to ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. AbbVie on Monday said it would buy ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. The Food and Drug Administration will ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...